Discounted Cash Flow (DCF) Analysis Levered
Creative Medical Technology Holding... (CELZ)
$0.4638
-0.02 (-3.38%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 0 | 0.12 | 0.17 | 0.16 | 0.09 | 0.63 | 4.54 | 32.67 | 234.99 | 1,690.45 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -0.89 | -1.05 | -1.21 | -0.43 | -2.22 | -28.91 | -208 | -1,496.26 | -10,763.56 | -77,428.90 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | - | - | - | - | - | -28.91 | -208 | -1,496.26 | -10,763.56 | -77,428.90 |
Weighted Average Cost Of Capital
| Share price | $ 0.4,638 |
|---|---|
| Beta | 4.798 |
| Diluted Shares Outstanding | 0.58 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 5.00% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 26.136 |
| Total Debt | - |
| Total Equity | 0.27 |
| Total Capital | 0.27 |
| Debt Weighting | 0.00 |
| Equity Weighting | 100.00 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 0 | 0.12 | 0.17 | 0.16 | 0.09 | 0.63 | 4.54 | 32.67 | 234.99 | 1,690.45 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -0.89 | -1.05 | -1.21 | -0.43 | -2.22 | -28.91 | -208 | -1,496.26 | -10,763.56 | -77,428.90 |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | -28.91 | -208 | -1,496.26 | -10,763.56 | -77,428.90 |
| WACC | ||||||||||
| PV LFCF | -22.92 | -130.72 | -745.50 | -4,251.52 | -24,245.94 | |||||
| SUM PV LFCF | -29,396.61 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 26.14 |
| Free cash flow (t + 1) | -78,977.47 |
| Terminal Value | -327,164.35 |
| Present Value of Terminal Value | -102,447.61 |
Intrinsic Value
| Enterprise Value | -131,844.22 |
|---|---|
| Net Debt | -10.72 |
| Equity Value | -131,833.50 |
| Shares Outstanding | 0.58 |
| Equity Value Per Share | -227,510.95 |